Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 11Unknown 2Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Carcinoma, Hepatocellular 46Liver Neoplasms 9Neoplasm Metastasis 4Leukemia, Myeloid, Acute 4Pancreatic Neoplasms 3Melanoma 3Carcinoma, Renal Cell 3Sarcoma 2Recurrence 2Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Breast Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Relapsed Pediatric Solid Tumor 1Portal Vein Tumor Thrombus 1Neoplasms, Glandular and Epithelial 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Site 1Neoplasms by Histologic Type 1Mesothelioma 1Lung Neoplasms 1Liver Diseases 1Leukemia, Monocytic, Acute 1Kidney Neoplasms 1Hemangiosarcoma 1HCC 1Gastrointestinal Neoplasms 1

Interventions

Doxorubicin 19Radiotherapy 10Ifosfamide 10apatinib 9anlotinib 8Cyclophosphamide 8camrelizumab 7Vincristine 5Dactinomycin 5toripalimab 3Trabectedin 3Radiation Dose Hypofractionation 3Etoposide 3Docetaxel 3ribociclib 2brostallicin 2Topotecan 2Thalidomide 2Temozolomide 2Sorafenib 2Oncolytic Virotherapy 2Nivolumab 2Neoadjuvant Therapy 2Melphalan 2Magnetic Resonance Spectroscopy 2Irinotecan 2Ipilimumab 2Immune Checkpoint Inhibitors 2Gene Expression Profiling 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Sarcoma × Sorafenib × Clear all
NCT00874874 2009-12-24

Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
96 enrolled
Sarcoma

Hemangiosarcoma, Sarcoma

NCT00541840 2008-05-12

Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma

Grupo Espanol de Investigacion en Sarcomas

Phase 1/2 Unknown
24 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡